StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > More LinkedIn

<< Previous

Bullboard Posts

Next >>

Comment by molotov420on Mar 09, 2022 9:51pm

118 Views

Post# 34501700

RE:RE:RE:More LinkedIn

What are they actually doing when they raise money to "accelerate the growth strategy"? They copy and past the same text on the last couple of PPs but should really provide more details. "accelerate the growth strategy by....xyz" Come on Tripp!

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1